• Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)
    • Services
      • Equity Reports (Analyst-Ready)
      • Visibility Upgrades (Quartely + As needed)
      • Investor Mapping
    • Press
    • Contact
    • English
      • Deutsch (German)
      • 日本語 (Japanese)
  • info@vasro.net
  • +49 (0)69 90 28 39 81
  • Call us Mon - Fri: 8:30 AM - 6:00 PM
VASRO GmbH
VASRO GmbH
  • Services
    • Equity Reports (Analyst-Ready)
    • Visibility Upgrades (Quartely + As needed)
    • Investor Mapping
  • Press
  • Contact
  • English
    • Deutsch (German)
    • 日本語 (Japanese)

Equity Research Coverage

VASRO GmbH > Press > Equity Research Coverage

Spinneys 1961 Holding PLC (Dubai Financial Market: SPIN) — Initial Equity Report (Non-Rated) | Premium Fresh-Led Grocery + Scalable Expansion Playbook

  • February 5, 2026
  • Equity Research Coverage
This initiating report is designed to do one thing well: translate Spinneys from a “known brand” into a trackable operating equity narrative that investors and internal decision-makers can underwrite....
Continue Reading

Ainos Update — AI Nose Expands into Robotic Sensing for Inspection & Safety Monitoring (Mirle Automation Partnership)

  • February 3, 2026
  • Equity Research Coverage
This update isolates a specific operational development: Ainos announced a technology partnership with Mirle Automation Corporation to integrate AI Nose into mobile and quadruped robotic platforms, positioning scent as...
Continue Reading

Ainos, Inc. (NASDAQ: AIMD) — Initial Equity Report (Non-Rated) | Two Engines: AI Nose Execution + VELDONA® Clinical Gates

  • January 20, 2026
  • Equity Research Coverage
This initiating publication is built to do one job: turn Ainos into a monitorable equity narrative with clear execution gates, instead of a “story stock” people talk about but...
Continue Reading

Posts pagination

Previous 1 2 3

Search

Categories

  • Energy
  • Equity Analysis reports
  • Equity Research Coverage
  • Market Intelligence
  • Pharma & Biotech
  • Tech
  • Unkategorisiert

Recent Posts

Ainos, Inc.: Three Patents Approved in Japan, and a Dataset Gathering Pace September 11, 2026
Baladna: The Capital Is Raised, Algeria Is Building – VASRO Reiterates BUY at QAR 2.33 September 7, 2026
Sirnaomics Ltd.: Every Approved siRNA Drug Works in the Liver. This One Was Injected Into Skin Cancer. VASRO Initiates Coverage With BUY September 7, 2026
Zaptec ASA: Europe’s Largest AC Charging Brand, With the Service Layer Priced at Zero – VASRO Initiates Coverage With BUY August 31, 2026
Spinneys 1961 Holding PLC: The Estate Grew 17%, Demand Did Not — First Half 2026 Update August 12, 2026
VASRO GmbH
VASRO GmbH specializes in equity analysis, market intelligence, and investment strategy for the pharmaceutical, biotechnology, and IT sectors. We deliver tailored insights to drive informed investment decisions and achieve exceptional results.

Discover More

Contact Info

  • Am Hauptbahnhof 16, 60329 Frankfurt am Main, Germany
  • +49 (0)69 90 28 39 81
  • Info@vasro.net
  • 8:30 AM - 6:00 PM

Navigation

  • Imprint
  • Privacy Policy
  • Change privacy settings
  • Application
  • About
  • FAQ

©copyright 2025 VASRO GmbH.